Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Dynamic Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzymatic route for amino alcohol intermediates reduces waste and improves chirality. Reliable supply chain partner for scalable pharmaceutical manufacturing.
Discover a novel dynamic resolution method for alpha-substituted-2-aminoacetamides achieving 98% yield. Ideal for pharmaceutical and agrochemical intermediate manufacturing.
Patent CN105063161B reveals high-purity R-1-aminoindane production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116024282B details enzymatic dynamic kinetic resolution for high purity S nornicotine offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104805148A details a novel enzymatic route for (1R,2S)-N-pyrrolidyl norephedrine. This method eliminates controlled precursors, offering significant cost and supply chain advantages for API manufacturers.
Patent CN105063162A reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability in pharmaceutical manufacturing processes.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Advanced biocatalytic dynamic kinetic resolution patent CN103820521B enables high-purity pharmaceutical intermediate manufacturing with substantial cost reduction and supply reliability.
Patent CN1322200A details a scalable enantioselective synthesis for non-steroidal antiestrogen intermediates. Discover cost reduction in pharmaceutical manufacturing and supply chain advantages.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN110467539B reveals a cost-effective dynamic kinetic resolution for 2,6-dimethyl-L-tyrosine, eliminating noble metals and enhancing supply chain stability for peptide manufacturers.
Patent CN104151352B reveals a high-purity Sofosbuvir intermediate method. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN104152527B details a novel DKR method for R-2-naphthylethylamine. Achieve high yield and optical purity with cost-effective Raney nickel catalysts for scalable supply.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN104263803B enables high-purity S-2-tetrahydronaphthalene amines production with superior yield and optical purity for reliable pharmaceutical intermediates supply chains.
Patent CN105063164A reveals DKR method for S-6-Methoxy-1-Aminoindane. High purity and yield offer supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN105154513A analysis reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN105154514A enables high-purity (S)-5-methyl-1-aminoindane via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.